This study is an open label trial designed to test the effectiveness of the Tennant Biomodulator® PRO electrical stimulation device (Avazzia), which uses BEST™ (Bio-Electric Stimulation Technology), on hospital in-patients to improve perfusion in the treated and contralateral limb.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
6
High-voltage pulsed current (HVPC) electrical stimulation with Reactions and BEST™ (Bio-Electric Stimulation Technology) microcurrent that measure and change with tissue electrical characteristics.
University of Texas Southwestern Medical Center, Department of Plastic Surgery
Dallas, Texas, United States
Improvement in perfusion up to 3 hours
Change in skin perfusion will be assessed by Skin Perfusion Pressure Test (SPP)
Time frame: 3 hours
Improvement in perfusion up to 3 hours
Change in skin perfusion will be assessed by Hyperspectral Imaging (HSI)
Time frame: 3 hours
Duration of BEST-induced perfusion effects
To compare the duration of BEST™ (Bio-Electric Stimulation Technology) induced perfusion effects
Time frame: 3 hours
Changes in reported pain after BEST™ (Bio-Electric Stimulation Technology) administration, at the point perfusion returns to baseline, and at 24 hours after treatment
Pain will be assessed with the Visual Analog Scale (VAS) labeled from '0': no pain to '10': worst pain imaginable
Time frame: 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.